ACTOFERRIN FOR PREVENTION OF COVID-19 IN HEALTH CARE PERSONNEL.

Not Applicable

Recruiting

• Conditions: B342; -B342 Coronavirus infection, unspecified site; Coronavirus infection, unspecified site

• Registration Number: PER-064-20
• Lead Sponsor: IVERSIDAD PERUANA CAYETANO HEREDIA,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-09-29
• Study Completion: 2021-03-05
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 209

Inclusion Criteria

1.- Man or woman over 18 and under 60 years old.
2.- Physicians or nurses who work in areas of care for patients with COVID-19 (emergency, hospitalization, and ICU) in hospitals in Lima, Peru.
3.- Healthy participants, without COVID-19 suggestive symptoms.
4.- Participant who wants to participate and signs the informed consent.

Exclusion Criteria

1.- Participant who had a previous diagnosis of COVID-19.
2.- Participant positive in the initial screening for IgM or IgG positive RT-PCR for COVID-19.
3.- Participant with the following comorbidities: hypertension, coronary heart disease, diabetes mellitus, obesity, chronic lung disease, cancer, kidney failure, or other hematological /and immunosuppressive diseases.
4.- Pregnant woman.
5.- Participant that are part of another clinical trial or is receiving any supplement or preventive treatment for COVID 19.
6.- Participant with known allergy to cow´s milk protein.

Study & Design

• Study Type: Interventional
• Study Design: Not specified